Toggle navigation
Home
Search
Services
Blog
Contact
About
Technetium Labeled Antibodies for Diagnosis
Reno, John M.
Neorx Corporation, Seattle, WA, United States
Search 3 grants from John Reno
Search grants from Neorx Corporation
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Fred Hutchinson Cancer Research Center
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Genetic &Clinical Risk for Human SLE Nephritis
Mass Spectrometry of Protein Assemblies
Therapy of Osteoporosis in Men with Parathyroid Hormone
Pulsed Amperometric Sensor for Nitric Oxide Detection
Cognition in Long Term Recall of Physical Activity
Recently added grants:
Viral Replication Pathways During Oral Tumorigenesis and Response to Therapy
Disseminating an Evidence-Based Tobacco Control intervention for School Teachers in India
Interactions between attention and arousal in shaping V4 population activity in macaque
Optogenetic manipulation of cortical feedback for controlling network coding and behavior
Inhibition of lysosomal flux in carcinogen-induced head and neck cancer
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Treatment (NCI)
Type
Small Business Innovation Research – Phase I (N43)
Project #
N43CM067940-001
Application #
3614580
Study Section
Project Start
1986-09-24
Project End
Budget Start
1986-11-01
Budget End
1987-03-31
Support Year
Fiscal Year
1987
Total Cost
Indirect Cost
Institution
Name
Neorx Corporation
Department
Type
DUNS #
City
Seattle
State
WA
Country
United States
Zip Code
98119
Related projects
NIH 1987
N43 CM
Technetium Labeled Antibodies for Diagnosis
Reno, John M. / Neorx Corporation
NIH 1986
N43 CM
Technetium Labeled Antibodies for Diagnosis
Reno, John M. / Neorx Corporation
Comments
Be the first to comment on this grant